EUVIMEDEUVIMED entdecken
Crossref

Quantification of Bullatine A and Bullatine B in Rat Plasma Using UPLC–MS/MS and Application to Pharmacokinetics

Hao Liu, Chen Gan, Yuxin Wu, Chenyao Xu, Congcong Wen iD, Xintao Dai

Biomedical Chromatography · 2026-07 · 40 (7)

DOI: 10.1002/bmc.70519 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 10.06.2026. Verfasst von Hao Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Inner Mongolia Minzu University, Tongliao, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Liquid Chromatography-Mass Spectrometry. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Basic Scientific Research Fund Projects for Directly Affiliated Universities in Inner Mongolia Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A highly specific and sensitive UPLC–MS/MS assay was established and validated for simultaneous determination of bullatine A and bullatolide B in rat plasma. Midazolam was employed as the internal standard (IS). Separation was performed on a Waters UPLC BEH C18 column using a gradient mobile phase consisting of methanol and 0.1% aqueous formic acid. Detection was carried out in the mode of multiple reaction monitoring (MRM), m/z 344.3 → 105.0 (bullatine A), m/z 438.6 → 154.2 (bullatine B), and m/z 326.2 → 291.4 (IS). Plasma proteins were effectively precipitated with acetonitrile prior to analysis. Good linear calibration curves ( r 2 > 0.995) were obtained in a range of 0.5–600 ng/mL for both analytes, with a limit of quantification of 0.5 ng/mL. Both intra‐ and inter‐day precision (percent RSD) were less than 14% for bullatine A and less than 13% for bullatine B. Accuracy (percentage nominal concentration) was within the range of 91%–109% for all quality control levels. The proposed method exhibited excellent sensitivity and selectivity and was successfully applied to compare the pharmacokinetics following intravenous and oral administration in rats. The absolute oral bioavailability was determined to be 4.3% for bullatine A and 12.8% for bullatine B.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryLiquid Chromatography-Mass SpectrometryAnimalsRatsReproducibility of ResultsChromatography, High Pressure LiquidMaleLinear ModelsRats, Sprague-DawleyLimit of DetectionSensitivity and Specificity

Stichwörter der Autor:innen

UPLC–MS/MSbullatine Abullatine Bpharmacokinetics

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Inner Mongolia Minzu University, Tongliao, China.
  • Laboratory Animal Centre, Wenzhou Medical University, Wenzhou, China.
  • Department of Anesthesiology, The People's Hospital of Yuhuan, Taizhou, China.

ORCID-Profile: Congcong Wen

Förderung

  • Basic Scientific Research Fund Projects for Directly Affiliated Universities in Inner Mongolia Autonomous Region

Zitieren

APA

Liu, H., Gan, C., Wu, Y., Xu, C., Wen, C., & Dai, X. (2026). Quantification of Bullatine A and Bullatine B in Rat Plasma Using UPLC–MS/MS and Application to Pharmacokinetics. Biomedical Chromatography, 40(7). https://doi.org/10.1002/bmc.70519

Vancouver

Liu H, Gan C, Wu Y, Xu C, Wen C, Dai X. Quantification of Bullatine A and Bullatine B in Rat Plasma Using UPLC–MS/MS and Application to Pharmacokinetics. Biomedical Chromatography. 2026;40(7). doi:10.1002/bmc.70519

BibTeX
@article{Liu2026,
  author = {Liu, Hao and Gan, Chen and Wu, Yuxin and Xu, Chenyao and Wen, Congcong and Dai, Xintao},
  title = {Quantification of Bullatine A and Bullatine B in Rat Plasma Using UPLC–MS/MS and Application to Pharmacokinetics},
  journal = {Biomedical Chromatography},
  year = {2026},
  volume = {40},
  number = {7},
  doi = {10.1002/bmc.70519}
}
Kostenlos starten →